Most tumors of BRCA1 germ-line mutation carriers, especially those identified before the age of 50, share morphological characteristics with basal-like cancers [69,70] and exhibit a basal-like phenotype as determined by immunohistochemistry [71,72] or expression arrays [19]. This evidence concerns the gene BRCA1 and cancer.